Breakthroughs in Muscular Dystrophy
Join ASGCT and the Muscular Dystrophy Association in downtown Chicago for an unparalleled opportunity to delve into the latest advancements in research on gene and cell therapies for muscular dystrophy.
FDA Scientific Exchange 2024: Advancing Gene Editing Platforms for Rare Diseases
This Scientific Exchange with the FDA seeks to make progress on therapeutic development for rare conditions that are scientifically feasible but commercially non-viable.
Real-World Evidence Webinar Series: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice
The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), is hosting a public webinar as part of a series of webinars for FDA-issued guidance related to real-world evidence (RWE). This latest session in the webinar series will discuss the draft guidance: Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice.
WCBP Symposium
Stay tuned for more details
The Festival of Genomics & Biodata London
With well over 5,000 attendees the Festival is now the [...]
Advanced Therapies 2025
The Advanced Therapies Congress is Europe’s largest commerical cell and [...]
CRISPR MEDiCiNE 2025
Meet the global CRISPR Medicine community at the second CRISPR MEDiCiNE conference.
2nd International Conference on Human Genetics and Genetical Disorders
Human Genetics and Genetical Disorders-2025 extend our immense pleasure and honor [...]
ASGCT 2025
Stay tuned for more information on ASGCT's 2025 annual meeting. [...]
The Festival of Genomics & Biodata
The Festival is designed principally for scientists and clinicians who are [...]
Cell & Gene Therapy Summit 2025
We cordially invite you to The Global Cell & Gene [...]